-
-
-
-
-
-
-
NeuroPace (NPCE) Tops Q4 EPS by 10c
-
-
-
-
-
-
-
NeuroPace receives medicare reimbursement increases for RNS system procedures
-
-
-
-
-
-
-
NeuroPace Inc (NPCE) PT Lowered to $15 at Wells Fargo
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on NeuroPace Inc (NPCE)
-
-
-
-
-
-
-
NeuroPace (NPCE) Announces Preliminary Results from One-Year Data in NAUTILUS Study
-
-
-
-
-
-
-
NeuroPace (NPCE) reports strategic refocusing of product portfolio
-
-
-
-
-
-
-
NeuroPace (NPCE) Announces $65M Proposed Share Offering
-
446,796 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

